icosapent conjugate (Cellix Bio)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameicosapent conjugate (Cellix Bio)
Drug Alias Nameeicosapentaenoic acid conjugate (Cellix Bio)CLX-181
ClassificationSmall molecules > Lipid
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAdenomatous Polyposis Coli
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellix Bio Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellix Bio Pvt Ltd
Active IndicationsN/A
Inactive IndicationsAdenomatous Polyposis Coli

Other Information

ATC CodeN/A
Related LinksN/A